Valuation: Illumina, Inc.

Market Cap 29.37B 25.79B 23.99B 22.01B 41.36B 2,828B 41.99B 285B 111B 1,390B 110B 108B 4,807B P/E 2026 *
41.4x
P/E 2027 * 34.1x
Enterprise Value 29.86B 26.22B 24.39B 22.38B 42.05B 2,875B 42.7B 290B 113B 1,414B 112B 110B 4,888B EV / Sales 2026 *
6.53x
EV / Sales 2027 * 6.03x
Free-Float
75.39%
Yield 2026 *
-
Yield 2027 * -
1 day-1.41%
1 week+3.99%
Current month+10.39%
1 month+10.85%
3 months+51.78%
6 months+29.15%
Current year+47.98%
1 week 178.88
Extreme 178.88
199.14
1 month 173.24
Extreme 173.235
199.14
Current year 112.65
Extreme 112.65
199.14
1 year 88
Extreme 88
199.14
3 years 68.7
Extreme 68.7
199.14
5 years 68.7
Extreme 68.7
526
10 years 68.7
Extreme 68.7
555.77
Manager TitleAgeSince
Chief Executive Officer 51 25/09/2023
Director of Finance/CFO 50 15/04/2024
Chief Tech/Sci/R&D Officer 55 29/05/2025
Director TitleAgeSince
Director/Board Member 65 28/07/2016
Director/Board Member 66 01/01/2017
Director/Board Member 65 05/02/2019
Date Insider Type Main position Quantity % Market Cap.
30/06/26 Free

Director

167 0.0001%
30/06/26
Corvex Management LP
OtherCompany 0 0%
30/06/26 Free

Director

142 0.0001%
Change 5-day change 1-year change 3-year change Capi.($)
-1.41%+3.99%+80.31%+3.20% 29.37B
-0.71%+6.72%+19.63%-0.57% 211B
-0.52%-6.05%-5.58%-25.77% 135B
+1.65%-2.29%-30.93%+4.31% 119B
+1.54%+0.50%-58.34%-15.18% 65.77B
-1.42%-3.62%+9.01%-9.60% 47.58B
+3.03%-0.17%-26.81%-31.58% 44.44B
-0.84%+5.41%+15.14%+8.50% 39.14B
-2.02%+1.54%+25.53%+30.56% 36.79B
-2.22%-3.95%-21.09%-24.87% 27.56B
Average -0.29%+0.03%+0.69%-6.10% 75.57B
Weighted average by Cap. -0.09%+0.21%-2.10%-6.71%

Financials

2026 *2027 *
Net sales 4.57B 4.01B 3.73B 3.43B 6.44B 440B 6.54B 44.33B 17.32B 216B 17.16B 16.79B 748B 4.83B 4.24B 3.95B 3.62B 6.8B 465B 6.91B 46.86B 18.31B 229B 18.14B 17.74B 791B
Net income 724M 636M 591M 542M 1.02B 69.68B 1.03B 7.02B 2.74B 34.26B 2.72B 2.66B 118B 871M 765M 712M 653M 1.23B 83.93B 1.25B 8.45B 3.3B 41.26B 3.27B 3.2B 143B
Net Debt 492M 432M 401M 368M 692M 47.34B 703M 4.77B 1.86B 23.27B 1.85B 1.81B 80.46B -222M -195M -181M -166M -312M -21.33B -317M -2.15B -839M -10.49B -832M -814M -36.26B
Logo Illumina, Inc.
Illumina, Inc. specializes in DNA sequencing and array-based technologies, serving customers in research, clinical and applied markets. The Company's products are used for applications in the life sciences, oncology, reproductive health, agriculture, and other emerging segments. Its customers include genomic research centers, academic institutions, government laboratories, and hospitals, as well as pharmaceutical, biotechnology, commercial molecular diagnostic laboratories, and consumer genomics companies. Its comprehensive line of products addresses the scale of experimentation and breadth of functional analysis to advance disease research, drug development, and the development of molecular tests. It also specializes in data-driven proteomics technology. Its products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing services, microarray services, proactive instrument monitoring, and instrument services and training.
Employees
8,625
Date Price Change Volume
24/07/26 $194.09 -1.41% 1,301,036
23/07/26 $196.86 +3.14% 1,220,931
22/07/26 $190.87 -0.86% 1,551,517
21/07/26 $192.53 +4.25% 1,365,148
20/07/26 $184.68 -1.06% 1,497,335
Trader
Investor
Global
Quality
ESG MSCI
BBB
Sell
Consensus
Buy
Mean consensus
OUTPERFORM
Number of Analysts
20
Last Close Price
194.09USD
Average target price
172.53USD
Spread / Average Target
-11.11%

Quarterly revenue - Rate of surprise

  1. Stock Market
  2. Stocks
  3. ILMN Stock